KAYA17 jobs and careers
About KAYA17
KAYA17 is a Point-Of-Care Testing developer which has developed a 15-minute rapid Covid-19 saliva test. This test has an accuracy of 98% sensitivity and 100% specificity. Kaya17 is currently pending FDA approval for EUA of an Antigen test, and should hear back early 2021.
- Employees
- 11 to 50
Leadership
The top of KAYA17's org chart, with how many people report into each leader.
SD
Sulatha Dwarakanath, Ph.D.
Founder & CEO
1 report
KS
Kevin T. Seltzer
Chief Financial Officer
Jobs at KAYA17
No open positions right now. Explore more companies on TheJobsMap.